Table 3.
Scores of the additional clinical assessments prior and after intervention as well as at 6-months follow-up
| ID | FMA-UE (0–66) | Sensation (0–12) | ROM (0–24) | Pain (0–24) | Spasticity (0–20) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A | B | FU | A | B | FU | A | B | FU | A | B | FU | A | B | FU | |
| P1 | 63 | 66 | 64 | 12 | 12 | 12 | 24 | 24 | 24 | 24 | 24 | 24 | 0 | 0 | 0 |
| P2 | 18 | 17 | 22 | 10 | 11 | 12 | 21 | 20 | 21 | 22 | 23 | 23 | 7 | 9 | 5 |
| P3 | 42 | 46 | 45 | 10 | 12 | 11 | 19 | 22 | 24 | 18 | 23 | 18 | 4 | 4 | 4 |
| P4 | 35 | 40 | 39 | 12 | 12 | 12 | 22 | 22 | 22 | 23 | 21 | 21 | 2 | 3 | 3 |
| P5 | 51 | 56 | 52 | 12 | 12 | 12 | 19 | 22 | 21 | 21 | 23 | 23 | 5 | 5 | 3 |
| P6 | 44 | 49 | 47 | 12 | 12 | 12 | 21 | 21 | 22 | 23 | 22 | 24 | 4 | 3 | 1 |
| P7 | 15 | 15 | 15 | 8 | 7 | 7 | 21 | 21 | 23 | 23 | 23 | 23 | 9 | 10 | 8 |
FMA-UE Fugl-Meyer Assessment—Upper Extremity, ROM range of motion, A phase A (baseline), B phase B (post intervention), FU 6 months follow-up